Immunohistochemical subtypes predict the clinical outcome in high-risk node-negative breast cancer patients treated with adjuvant FEC regimen: results of a single-center retrospective study

BACKGROUND: Anthracycline-based adjuvant chemotherapy improves survival in patients with high-risk node-negative breast cancer (BC). In this setting, prognostic factors predicting for treatment failure might help selecting among the different available cytotoxic combinations. METHODS: Between 1998 a...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :BMC Cancer
Главные авторы: Rahal, S., Boher, J M, Extra, J M, Tarpin, C., Charafe-Jauffret, E., Lambaudie, E., Sabatier, R., Thomassin-Piana, J., Tallet, A., Resbeut, M., Houvenaeghel, G., Laborde, L., Bertucci, F., Viens, P., Gonçalves, A.
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2015
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4607139/
https://ncbi.nlm.nih.gov/pubmed/26466893
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1746-3
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы